光大嘉寶(600622.SH)擬申請發行資產支持專項計劃 規模不超17億元
格隆匯 9 月 23日丨光大嘉寶(600622.SH)公佈,為進一步拓寬融資渠道,降低融資成本,優化資本結構,滿足公司經營發展需要,根據法律、法規、規範性文件等有關規定,公司擬向上海證券交易所申請發行資產支持專項計劃進行融資。此次擬發行的資產支持專項計劃以公司下屬全資子公司上海嘉寶實業集團投資管理有限公司(“嘉寶投資”)根據《借款合同》持有的對光大嘉寶的借款為基礎資產,發行總規模不超過人民幣17億元(含17億元)。發行期限:不超過18年。
此次發行資產支持專項計劃有利於公司拓寬融資渠道,降低融資成本,優化資本結構,提高資金使用效率,不會對公司的日常經營和償債能力產生重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.